Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144


Survival advantages conferred to colon cancer cells by E-selectin-induced activation of the PI3K-NFκB survival axis downstream of Death receptor-3.

Porquet N, Poirier A, Houle F, Pin AL, Gout S, Tremblay PL, Paquet ER, Klinck R, Auger FA, Huot J.

BMC Cancer. 2011 Jul 1;11:285. doi: 10.1186/1471-2407-11-285.


Id-1 activation of PI3K/Akt/NFkappaB signaling pathway and its significance in promoting survival of esophageal cancer cells.

Li B, Cheung PY, Wang X, Tsao SW, Ling MT, Wong YC, Cheung AL.

Carcinogenesis. 2007 Nov;28(11):2313-20. Epub 2007 Jul 16.


RNA interference of PARG could inhibit the metastatic potency of colon carcinoma cells via PI3-kinase/Akt pathway.

Li Q, Li M, Wang YL, Fauzee NJ, Yang Y, Pan J, Yang L, Lazar A.

Cell Physiol Biochem. 2012;29(3-4):361-72. doi: 10.1159/000338491. Epub 2012 Apr 3. Erratum in: Cell Physiol Biochem. 2014;33(1):247-8.


Epidermal growth factor stimulates nuclear factor-κB activation and heme oxygenase-1 expression via c-Src, NADPH oxidase, PI3K, and Akt in human colon cancer cells.

Lien GS, Wu MS, Bien MY, Chen CH, Lin CH, Chen BC.

PLoS One. 2014 Aug 14;9(8):e104891. doi: 10.1371/journal.pone.0104891. eCollection 2014.


Src activation regulates anoikis in human colon tumor cell lines.

Windham TC, Parikh NU, Siwak DR, Summy JM, McConkey DJ, Kraker AJ, Gallick GE.

Oncogene. 2002 Nov 7;21(51):7797-807.


Regulation of transendothelial migration of colon cancer cells by E-selectin-mediated activation of p38 and ERK MAP kinases.

Tremblay PL, Auger FA, Huot J.

Oncogene. 2006 Oct 26;25(50):6563-73. Epub 2006 May 22.


Poly(I:C)-induced adhesion molecule expression mediated by NF-{kappa}B and phosphoinositide 3-kinase-Akt signaling pathways in human corneal fibroblasts.

Orita T, Kimura K, Zhou HY, Nishida T.

Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5556-60. doi: 10.1167/iovs.09-4909. Epub 2010 Jun 23.


Sulfatase 2 protects hepatocellular carcinoma cells against apoptosis induced by the PI3K inhibitor LY294002 and ERK and JNK kinase inhibitors.

Lai JP, Sandhu DS, Yu C, Moser CD, Hu C, Shire AM, Aderca I, Murphy LM, Adjei AA, Sanderson S, Roberts LR.

Liver Int. 2010 Nov;30(10):1522-8. doi: 10.1111/j.1478-3231.2010.02336.x. Epub 2010 Sep 8.


Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression.

Bharadwaj U, Marin-Muller C, Li M, Chen C, Yao Q.

Mol Cancer. 2011 Aug 31;10:106. doi: 10.1186/1476-4598-10-106.


Targeting PI3K/Akt/HSP90 signaling sensitizes gastric cancer cells to deoxycholate-induced apoptosis.

Redlak MJ, Miller TA.

Dig Dis Sci. 2011 Feb;56(2):323-9. doi: 10.1007/s10620-010-1294-2. Epub 2010 Jun 29.


Restoration of transforming growth factor-beta receptor II expression in colon cancer cells with microsatellite instability increases metastatic potential in vivo.

Liu XQ, Rajput A, Geng L, Ongchin M, Chaudhuri A, Wang J.

J Biol Chem. 2011 May 6;286(18):16082-90. doi: 10.1074/jbc.M111.221697. Epub 2011 Mar 17.


LY294002 enhances boswellic acid-induced apoptosis in colon cancer cells.

Liu JJ, Duan RD.

Anticancer Res. 2009 Aug;29(8):2987-91.


The PI3-kinase-Akt pathway promotes mesangial cell survival and inhibits apoptosis in vitro via NF-kappa B and Bad.

Shimamura H, Terada Y, Okado T, Tanaka H, Inoshita S, Sasaki S.

J Am Soc Nephrol. 2003 Jun;14(6):1427-34.

Supplemental Content

Support Center